Taysha Gene Therapies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TSHA and other ETFs, options, and stocks.About TSHA
Taysha Gene Therapies, Inc.is a patient-centric, clinical-stage gene therapy company, which engages in the development and commercialization of adeno-associated viruses (AAV) based gene therapies for the treatment of monogenic diseases of the central nervous system. It also develops multiple gene therapy platforms which include AAV9 Discovery, Novel Capsid, and AAV Redosing.
CEOSean P. Nolan
CEOSean P. Nolan
Employees52
Employees52
HeadquartersDallas, Texas
HeadquartersDallas, Texas
Founded2019
Founded2019
Employees52
Employees52
TSHA Key Statistics
Market cap481.57M
Market cap481.57M
Price-Earnings ratio-1.92
Price-Earnings ratio-1.92
Dividend yield—
Dividend yield—
Average volume1.32M
Average volume1.32M
High today$2.75
High today$2.75
Low today$2.54
Low today$2.54
Open price$2.65
Open price$2.65
Volume1.05M
Volume1.05M
52 Week high$3.89
52 Week high$3.89
52 Week low$0.50
52 Week low$0.50
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%